An approach to intravenous Iron therapy in patients receiving dialysis regularly

Phase 2

• Conditions: Health Condition 1: O- Medical and Surgical

• Registration Number: CTRI/2023/09/058062
• Lead Sponsor: Command Hospital Eastern Command

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

CKD patients on Maintenance dialysis (hemodialysis or peritoneal dialysis)

Age more than 18 years,

Duration of Maintenance Dialysis more than 60 days,

Hemoglobin less than 11g/dl,

Ferritin < 400 µg/l and TSAT < 30%

Follow up in Command Hospital, Eastern Command, Kolkata during study period

Exclusion Criteria

Current use of IV Iron therapy or Use of IV or Oral Iron Therapy within last 15days

Blood Transfusion in last one month

Active infection (bacterial, fungal)

Known HIV or Hepatitis B or C

Known / suspected diagnosis of autoimmune disease

Past or present diagnosis of malignancy

Known diagnosis of chronic liver disease

History of any bleeding diathesis

History of gastro-intestinal surgery in past 3 months

Present or past diagnosis of peptic ulcer disease or gastro-intestinal bleeding

History of severe allergic reactions to any form of intravenous iron preparations

Pregnancy or lactation, in case of females

Life expectancy < 1 year

History of acquired iron overload

Presence of Macrocytic anemia or Low Vitamin B12 level

Patient not giving consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified